Literature DB >> 23813212

APOL1 and progression of nondiabetic nephropathy.

Nicholette D Palmer, Barry I Freedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23813212      PMCID： PMC3752959          DOI： 10.1681/ASN.2013060589

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  9 in total

1.  Population-based risk assessment of APOL1 on renal disease.

Authors:  David J Friedman; Julia Kozlitina; Giulio Genovese; Prachi Jog; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

2.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

3.  APOL1 variants associate with increased risk of CKD among African Americans.

Authors:  Meredith C Foster; Josef Coresh; Myriam Fornage; Brad C Astor; Morgan Grams; Nora Franceschini; Eric Boerwinkle; Rulan S Parekh; W H Linda Kao
Journal:  J Am Soc Nephrol       Date:  2013-06-13       Impact factor: 10.121

4.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

Authors:  Allison E Ashley-Koch; Emmanuel C Okocha; Melanie E Garrett; Karen Soldano; Laura M De Castro; Jude C Jonassaint; Eugene P Orringer; James R Eckman; Marilyn J Telen
Journal:  Br J Haematol       Date:  2011-09-13       Impact factor: 6.998

5.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

6.  Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.

Authors:  Christopher P Larsen; Marjorie L Beggs; Mohammad Saeed; Patrick D Walker
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

7.  JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.

Authors:  Jasmin Divers; Marina Núñez; Kevin P High; Mariana Murea; Michael V Rocco; Lijun Ma; Donald W Bowden; Pamela J Hicks; Mitzie Spainhour; David A Ornelles; Steven B Kleiboeker; Kara Duncan; Carl D Langefeld; Jolyn Turner; Barry I Freedman
Journal:  Kidney Int       Date:  2013-05-15       Impact factor: 10.612

8.  Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.

Authors:  Barry I Freedman; Carl D Langefeld; Jolyn Turner; Marina Núñez; Kevin P High; Mitzie Spainhour; Pamela J Hicks; Donald W Bowden; Amber M Reeves-Daniel; Mariana Murea; Michael V Rocco; Jasmin Divers
Journal:  Kidney Int       Date:  2012-06-13       Impact factor: 10.612

9.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.

Authors:  Michael S Lipkowitz; Barry I Freedman; Carl D Langefeld; Mary E Comeau; Donald W Bowden; W H Linda Kao; Brad C Astor; Erwin P Bottinger; Sudha K Iyengar; Paul E Klotman; Richard G Freedman; Weijia Zhang; Rulan S Parekh; Michael J Choi; George W Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612
  9 in total
  16 in total

1.  Generalizability of genetic findings related to kidney function and albuminuria.

Authors:  Afshin Parsa; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

2.  End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.

Authors:  Barry I Freedman; Carl D Langefeld; Kelly K Andringa; Jennifer A Croker; Adrienne H Williams; Neva E Garner; Daniel J Birmingham; Lee A Hebert; Pamela J Hicks; Mark S Segal; Jeffrey C Edberg; Elizabeth E Brown; Graciela S Alarcón; Karen H Costenbader; Mary E Comeau; Lindsey A Criswell; John B Harley; Judith A James; Diane L Kamen; S Sam Lim; Joan T Merrill; Kathy L Sivils; Timothy B Niewold; Neha M Patel; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Jane E Salmon; Betty P Tsao; Keisha L Gibson; Joyce R Byers; Anna K Vinnikova; Janice P Lea; Bruce A Julian; Robert P Kimberly
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

3.  Race, APOL1 Risk, and eGFR Decline in the General Population.

Authors:  Morgan E Grams; Casey M Rebholz; Yuan Chen; Andreea M Rawlings; Michelle M Estrella; Elizabeth Selvin; Lawrence J Appel; Adrienne Tin; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2016-03-10       Impact factor: 10.121

4.  A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.

Authors:  Karl L Skorecki; Jessica H Lee; Carl D Langefeld; Saharon Rosset; Shay Tzur; Walter G Wasser; Revital Shemer; Gregory A Hawkins; Jasmin Divers; Rulan S Parekh; Man Li; Matthew G Sampson; Matthias Kretzler; Martin R Pollak; Shrijal Shah; Daniel Blackler; Brendan Nichols; Michael Wilmot; Seth L Alper; Barry I Freedman; David J Friedman
Journal:  Nephrol Dial Transplant       Date:  2018-02-01       Impact factor: 5.992

Review 5.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors:  Barry I Freedman; Karl Skorecki
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

6.  Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.

Authors:  Jae-Hyung Chang; S Ali Husain; Dominick Santoriello; Michael B Stokes; Clifford D Miles; Kirk W Foster; Yifu Li; Leigh-Anne Dale; Russell J Crew; David J Cohen; Krzysztof Kiryluk; Ali G Gharavi; Sumit Mohan
Journal:  Am J Kidney Dis       Date:  2018-07-25       Impact factor: 8.860

Review 7.  The Apolipoprotein L1 Gene and Cardiovascular Disease.

Authors:  Todd W Robinson; Barry I Freedman
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 8.  Apolipoprotein L1 Gene Effects on Kidney Transplantation.

Authors:  Barry I Freedman; Jayme E Locke; Amber M Reeves-Daniel; Bruce A Julian
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

9.  APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.

Authors:  Barry I Freedman; Stephen O Pastan; Ajay K Israni; David Schladt; Bruce A Julian; Michael D Gautreaux; Vera Hauptfeld; Robert A Bray; Howard M Gebel; Allan D Kirk; Robert S Gaston; Jeffrey Rogers; Alan C Farney; Giuseppe Orlando; Robert J Stratta; Sumit Mohan; Lijun Ma; Carl D Langefeld; Donald W Bowden; Pamela J Hicks; Nicholette D Palmer; Amudha Palanisamy; Amber M Reeves-Daniel; W Mark Brown; Jasmin Divers
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

10.  Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.

Authors:  Gregory A Hawkins; David J Friedman; Lingyi Lu; David R McWilliams; Jeff W Chou; Satria Sajuthi; Jasmin Divers; Rulan S Parekh; Man Li; Giulio Genovese; Martin R Pollack; Pamela J Hicks; Donald W Bowden; Lijun Ma; Barry I Freedman; Carl D Langefeld
Journal:  Am J Nephrol       Date:  2015-09-08       Impact factor: 3.754
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.